Artigo Revisado por pares

Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody

2001; Springer Science+Business Media; Volume: 74; Issue: 1 Linguagem: Inglês

10.1007/bf02982552

ISSN

1865-3774

Autores

Takahiro Maeda, Yasuaki Yamada, Masayuki Tawara, Reishi Yamasaki, Yuichi Yakata, Chizuko Tsutsumi, Yasuyuki Onimaru, Simeru Kamihira, Masao Tomonaga,

Tópico(s)

Vascular Tumors and Angiosarcomas

Referência(s)